Inhibikase Therapeutics, Inc.
IKTNASDAQHealthcareBiotechnology
$1.63Today:- (-)1Y +6.54%
As of Oct 22, 2026 close
- Market cap
- $284.55M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.33$2.61
- Volume (live)
- -
- Avg. volume (3M)
- 659.99K
Inhibikase Therapeutics, Inc. (IKT) Dividends
Inhibikase Therapeutics, Inc. does not currently pay dividends, or its dividend history is not available.